Royston Aaron
- SEC CIK
- 0001727703
No open-market purchases or sales filed in the past year.
Current role at each company
- ACHV Achieve Life Sciences, Inc.Directoras of Jul 29, 2026
- VTYX Ventyx Biosciences, Inc.Directoras of Apr 26, 2023
- Elevation Oncology, Inc.10% Owneras of May 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Royston Aaron as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Elevation Oncology, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2022 (view filing)7:20 PM ET | May 25 | 2 days | Goodman Corey S and 4 others10% Owner | SSale | −702.7K | $4.12 | −$2.90M | −26.9%1.91M after | |
| Jul 1, 2021 (view filing)5:27 PM ET | Jun 29 | 2 days | Goodman Corey S and 4 others10% Owner | PPurchase | +625.0K | $16.00 | +$10.0M | +31.5%2.61M after |
VTYX Ventyx Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2021 (view filing) | Oct 25 | Same day | Royston AaronDirector, 10% Owner | PPurchase | +312.5K | $16.00 | +$5.00M | +8.5%4.00M after |